Systemic hypertension and nondiabetic chronic kidney disease: the best evidence-based therapeutic approach today.
Despite the high prevalence and significant morbidity and mortality associated with high chronic kidney disease (CKD) in patients with hypertension, it remains vastly under-diagnosed and under-treated. Consequently, many patients develop kidney failure requiring dialysis or kidney transplant. Moreover, patients with CKD represent the group at highest risk from cardiovascular complications, even greater than patients with diabetes mellitus. Therefore, management of hypertension in such patients needs to be more aggressive compared to those with normal kidney function. This review provides guidelines for treatment of hypertension in patients with non-diabetic CKD based on updated evidence from clinical trials data. Following these recommendations is likely to minimize the risk of development of kidney failure and cardiovascular disease.
Jafar
T H
TH
Section of Nephrology, Department of Medicine, Aga Khan University - Karachi (Pakistan).
D000419:Albuminuria / Q000150:complications / Q000503:physiopathology; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002908:Chronic Disease; D006801:Humans; D006977:Hypertension, Renal / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D007674:Kidney Diseases / Q000503:physiopathology / Q000628:therapy*; D007676:Kidney Failure, Chronic / Q000503:physiopathology / Q000628:therapy
D000959:Antihypertensive Agents